Clinical Trials Browser

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06660862 2026-01-08

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Phase 4 Not yet recruiting

80 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT06980103 2026-01-08

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

Phase NA Recruiting

408 enrolled

Head & Neck

Thyroid Neoplasms

NCT07312760 2025-12-31

Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)

Phase NA Recruiting

160 enrolled

Death, Pyloric Stenosis, Hypertrophic

NCT07307456 2025-12-29

Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

Phase 2 Recruiting

31 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT07301424 2025-12-24

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

Phase 2 Not yet recruiting

80 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06492759 2025-12-16

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

Phase 2 Not yet recruiting

29 enrolled

Breast

Triple Negative Breast Neoplasms

NCT04345718 2025-12-09

EXHITENTRE

Phase 2/3 Completed

344 enrolled

Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

NCT07181278 2025-12-02

OptiTri_MT

Phase NA Recruiting

1,180 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02023463 2025-11-25

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

Phase 1 Active not recruiting

25 enrolled

Genitourinary

Prostatic Neoplasms

NCT07239622 2025-11-20

Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma

Phase 2 Not yet recruiting

36 enrolled

Gynecologic

Ovarian Neoplasms

NCT07091032 2025-11-18

Building Connections

Phase NA Recruiting

3,600 enrolled

GastrointestinalGynecologicOther

Anxiety Disorders, Uterine Cervical Neoplasms, Colonic Neoplasms, Depression, Obesity

NCT06180460 2025-10-08

CALM: Managing Distress in Malignant Brain Cancer

Phase NA Completed

60 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma

NCT06582784 2025-10-07

IMPACT

Phase NA Recruiting

279 enrolled

Depression, Neoplasms

NCT07180901 2025-09-18

PRONTO-HN

Phase NA Recruiting

85 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT00819208 2025-09-16

CHALLENGE

Phase NA Active not recruiting

889 enrolled

Gastrointestinal

Anxiety Disorders, Colonic Neoplasms, Depression, Fatigue, Sleep Wake Disorders, Colorectal Neoplasms

NCT04961047 2025-09-15

Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors

Phase NA Completed

36 enrolled

Depression

NCT07137819 2025-08-22

EXACT-1

Phase 3 Recruiting

280 enrolled

Dermatologic

Keratosis, Actinic

NCT06947577 2025-08-20

PEMFTEPCHIN

Phase 4 Completed

80 enrolled

Agnosia

NCT06057675 2025-08-19

Tranexamic Acid in Nasal Mohs Reconstruction

Phase 2 Recruiting

100 enrolled

Postoperative Hemorrhage

NCT07130942 2025-08-19

Molecular Hydrogen Inhalation: Effects on Health, Exercise Capacity and Inflammatory Response - in Vivo/in Vitro Studies

Phase NA Not yet recruiting

250 enrolled

Respiratory Aspiration

NCT05655546 2025-08-08

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Phase NA Terminated

2,117 enrolled 6 charts

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Graft vs Host Disease, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, HIV Infections

NCT07110259 2025-08-07

AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study

Phase NA Not yet recruiting

950 enrolled

Thoracic

Non Small Cell Lung Caner

NCT05444348 2025-07-29

ACT

Phase NA Recruiting

920 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06765707 2025-07-24

SyMPTOM

Phase NA Enrolling by invitation

225 enrolled

Breast

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT05415007 2025-07-15

GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer

Phase NA Recruiting

40 enrolled

Tumor-Agnostic

Neoplasms

Clinical Trials

SNIFF

JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis

STOP-CLL-DCT

CARES-Lite

PBM-LEF

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Evolut™ EXPAND TAVR II Pivotal Trial

STEPS-BC

Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

INSPIRE

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

ARETHUSA

Effect of Transfer Energy Capacitive and Resistive Therapy on Palmar Fibromatosis

FOCALE

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma

Niraparib In Recurrent IDH 1/2 Gliomas

Cervical Thermal Ablation to Treat Persistent HPV Infection

A-319

Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma

Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Epithelial Ovarian Cancer.

CRANIO4US

Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)

Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

EXHITENTRE

OptiTri_MT

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma

Building Connections

CALM: Managing Distress in Malignant Brain Cancer

IMPACT

PRONTO-HN

CHALLENGE

Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors

EXACT-1

PEMFTEPCHIN

Tranexamic Acid in Nasal Mohs Reconstruction

Molecular Hydrogen Inhalation: Effects on Health, Exercise Capacity and Inflammatory Response - in Vivo/in Vitro Studies

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study

ACT

SyMPTOM

GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer